{
    "clinical_study": {
        "@rank": "129306", 
        "arm_group": [
            {
                "arm_group_label": "Cases", 
                "description": "Hip fracture patients participating in a randomised controlled trial (RCT) of orthogeriatric care (ClinicalTrials.gov NCT01009268)"
            }, 
            {
                "arm_group_label": "Controls", 
                "description": "A group of voluntary elderly persons without a history of hip fracture, recruited specifically for this purpose"
            }
        ], 
        "biospec_descr": {
            "textblock": "For vitamin and hormone analysis serum was collected For some vitamin analysis EDTA blood\n      was collected For RNA analysis fullblood was collected"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Low Body Mass Index (BMI) is a risk factor for hip fracture, but it is unknown if it is the\n      low BMI per se that increases risk of hip fracture or if specific micro-nutrients\n      contribute. The investigators want to elucidate this aspect in a case control study studying\n      micronutrients in serum and bone turnover markers of hip fracture patients compared with\n      controls of the same age."
        }, 
        "brief_title": "Nutritional Risk Factors for Hip Fracture: a Case Control Study", 
        "completion_date": {
            "#text": "April 2011", 
            "@type": "Actual"
        }, 
        "condition": "Hip Fracture", 
        "condition_browse": {
            "mesh_term": [
                "Fractures, Bone", 
                "Hip Fractures"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Cases are admitted acutely for a femoral neck fracture, a trochanteric or a\n        subtrochanteric femoral fracture.\n\n        Exclusion Criteria:\n\n          -  Hip fracture as part of multi-trauma or high energy trauma (defined as a fall from a\n             higher level than 1 metre). One recent fracture in addition to the hip fracture (e.g.\n             radius or shoulder) is acceptable.\n\n          -  Regarded as moribund at admittance.\n\n          -  Absence of a valid informed consent or assent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Cases: The first 116 patients of an ongoing RCT were included consecutively and examined\n        by blood samples pre operatively for nutrition and hormone analysis. The catchment area\n        for the cases was the city of Oslo, Norway.\n\n        A control group, at the same age with no history of hip fracture, was drawn at random from\n        inhabitants aged 60 - 100 years (median age 82 years) at the census files of Oslo in 2005."
            }
        }, 
        "enrollment": {
            "#text": "184", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01738776", 
            "org_study_id": "S-0916901(REK)", 
            "secondary_id": "120000MM"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "hip fracture", 
            "risk factors", 
            "vitamin K1", 
            "vitamin D", 
            "bone turnover markers", 
            "osteocalcin", 
            "undercarboxylated osteocalcin", 
            "bone specific alkaline phosphatase (BALP)", 
            "insulin like growth factor 1 (IGF1)", 
            "parathyroid hormone (PTH)"
        ], 
        "lastchanged_date": "November 30, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Oslo", 
                    "country": "Norway", 
                    "zip": "0424"
                }, 
                "name": "University of Oslo, Institute of Clinical Medicine"
            }
        }, 
        "location_countries": {
            "country": "Norway"
        }, 
        "number_of_groups": "2", 
        "official_title": "Nutritional Risk Factors for Hip Fracture: a Case Control Study", 
        "overall_official": {
            "affiliation": "Oslo University Hospital", 
            "last_name": "Morten Mowe, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Norway: Regional Ethics Commitee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Blood was drawn for micronutrient analysis in hip fracture patients and in controls", 
            "measure": "micronutrient association with increased risk of hip fracture", 
            "safety_issue": "No", 
            "time_frame": "At admission"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01738776"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Oslo University Hospital", 
            "investigator_full_name": "Anne Torbergsen", 
            "investigator_title": "Clinical Nutritionist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Blood was drawn for bone turnover analysis. Correlation analysis with micronutrients was performed", 
            "measure": "Are micronutrients related to bone turnover markers", 
            "safety_issue": "No", 
            "time_frame": "At admission"
        }, 
        "source": "Oslo University Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Oslo", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Oslo University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2009", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "November 2012"
    }
}